We are live on ! Find out more
II

Inspire Investing Portfolio holdings

AUM $2.43B
1-Year Est. Return 49.04%
This Fund
S&P 500
This Quarter Est. Return
+24.71%
1 Year Est. Return
+49.04%
3 Year Est. Return
+108.47%
5 Year Est. Return
+128.46%
10 Year Est. Return
AUM
$2.43B
AUM Growth
+$720M
Cap. Flow
+$434M
Cap. Flow %
17.83%
Top 10 Hldgs %
19.05%
Holding
1,340
New
232
Increased
677
Reduced
261
Closed
74

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$32.6M
2
AVGO icon
Broadcom
AVGO
+$16.2M
3
GEV icon
GE Vernova
GEV
+$14.2M
4
LIN icon
Linde
LIN
+$12.4M
5
NEE icon
NextEra Energy
NEE
+$9.03M

Top Sells

Rank Stock Value
1
PLD icon
Prologis
PLD
+$19.2M
2
NEM icon
Newmont
NEM
+$9.51M
3
FTNT icon
Fortinet
FTNT
+$8.74M
4
QCOM icon
Qualcomm
QCOM
+$6.4M
5
IDCC icon
InterDigital
IDCC
+$6.06M

Sector Composition

Rank Sector Weight
1 Technology 27%
2 Industrials 20.23%
3 Financials 9.37%
4 Energy 6.81%
5 Consumer Discretionary 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIDI icon
1226
Vident International Equity Strategy
VIDI
$466M
$38 ﹤0.01%
1
CLDX icon
1227
Celldex Therapeutics
CLDX
$3.12B
$37 ﹤0.01%
1
VGNT
1228
Versigent PLC
VGNT
$3.56B
$37 ﹤0.01%
+1
New +$40
OPENW
1229
Opendoor Technologies Inc Series K Warrants
OPENW
$5.32M
$36 ﹤0.01%
72
RKT icon
1230
Rocket Companies
RKT
$39.8B
$32 ﹤0.01%
2
DARE icon
1231
Dare Bioscience
DARE
$14M
$31 ﹤0.01%
14
CRSP icon
1232
CRISPR Therapeutics
CRSP
$5.39B
$29 ﹤0.01%
1
GMAB icon
1233
Genmab
GMAB
$20.7B
$25 ﹤0.01%
1
CTMX icon
1234
CytomX Therapeutics
CTMX
$808M
$24 ﹤0.01%
6
CRNX
1235
DELISTED
Crinetics Pharmaceuticals
CRNX
$23 ﹤0.01%
1
TCRT icon
1236
Alaunos Therapeutics
TCRT
$4.14M
$20 ﹤0.01%
9
OPENL
1237
Opendoor Technologies Inc Series A Warrants
OPENL
$3.64M
$20 ﹤0.01%
72
CLLS
1238
Cellectis
CLLS
$326M
$18 ﹤0.01%
6
ELME
1239
Elme Communities
ELME
$150M
$18 ﹤0.01%
12
OPENZ
1240
Opendoor Technologies Inc Series Z Warrants
OPENZ
$3.38M
$17 ﹤0.01%
72
BP icon
1241
BP
BP
$113B
0
VSTM icon
1242
Verastem
VSTM
$743M
$15 ﹤0.01%
4
NWSA icon
1243
News Corp Class A
NWSA
$16.3B
0
HAIN icon
1244
Hain Celestial
HAIN
$67.5M
$8 ﹤0.01%
14
-10
-42% -$7
PEGA icon
1245
Pegasystems
PEGA
$6.14B
0
PHUN icon
1246
Phunware
PHUN
$42.6M
$6 ﹤0.01%
3
VBND icon
1247
Vident US Bond Strategy ETF
VBND
$523M
0
ADV icon
1248
Advantage Solutions
ADV
$403M
-22,270
Closed -$471K
AL
1249
DELISTED
Air Lease Corp
AL
-6,850
Closed -$445K
ASRT
1250
DELISTED
Assertio
ASRT
-3
Closed -$59

Similar funds

Inspire Investing's Q2 2026 Portfolio in Review

As of Q2 2026, Inspire Investing held 1,340 positions worth $2.43B, up 42% from $1.71B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Inspire Investing deployed $434M of net new capital in Q2 2026, opening 232 new positions and adding to 677 existing holdings. Its largest new stake was ExxonMobil: 218,045 shares worth $29.8M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Prologis, an estimated $19.2M trimmed.

  • Inspire Investing's largest Q2 2026 buy was ExxonMobil: 218,045 shares worth $29.8M.
  • Inspire Investing added most to Broadcom in Q2 2026, an estimated $16.2M increase.
  • Inspire Investing's biggest Q2 2026 reduction was Prologis, cutting an estimated $19.2M.
  • Inspire Investing fully exited Fortinet in Q2 2026, selling an estimated $8.74M.
  • Inspire Investing's ten largest holdings make up 19% of its $2.43B portfolio in Q2 2026.
  • Inspire Investing opened 232 new positions and closed 74 in Q2 2026.
  • Inspire Investing's portfolio value rose 42% quarter-over-quarter to $2.43B.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.